Cite
miR-495 enhances the efficacy of radiotherapy by targeting GRP78 to regulate EMT in nasopharyngeal carcinoma cells
MLA
Wuwu Lv, et al. “MiR-495 Enhances the Efficacy of Radiotherapy by Targeting GRP78 to Regulate EMT in Nasopharyngeal Carcinoma Cells.” Oncology Reports, vol. 40, no. 3, July 2018, pp. 1223–32. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3c44b26b2648dbcc9947bb6d68c1df4c&authtype=sso&custid=ns315887.
APA
Wuwu Lv, Qian He, Shuanglian Wang, & Xueping Feng. (2018). miR-495 enhances the efficacy of radiotherapy by targeting GRP78 to regulate EMT in nasopharyngeal carcinoma cells. Oncology Reports, 40(3), 1223–1232.
Chicago
Wuwu Lv, Qian He, Shuanglian Wang, and Xueping Feng. 2018. “MiR-495 Enhances the Efficacy of Radiotherapy by Targeting GRP78 to Regulate EMT in Nasopharyngeal Carcinoma Cells.” Oncology Reports 40 (3): 1223–32. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3c44b26b2648dbcc9947bb6d68c1df4c&authtype=sso&custid=ns315887.